The Discounted Cash Flow (DCF) valuation of AnaptysBio Inc (ANAB) is (431.17) USD. With the latest stock price at 36.58 USD, the upside of AnaptysBio Inc based on DCF is -1278.7%.
Based on the latest price of 36.58 USD and our DCF valuation, AnaptysBio Inc (ANAB) is a sell. selling AnaptysBio stocks now will result in a potential gain of 1278.7%.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| WACC / Discount Rate | 7.2% - 8.6% | 7.9% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | (751.82) - (306.44) | (431.17) |
| Upside | -2155.3% - -937.7% | -1278.7% |